Research programme: Gene editing therapies - Prime Medicine
Latest Information Update: 28 Aug 2023
At a glance
- Originator Prime Medicine
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified